ADVANCED ENZYME TECHNOLOGIES
Back to Cashflow Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-70 Cr | ₹-73 Cr | ₹-59 Cr | ₹-26 Cr | ₹-49 Cr |
What is the latest Cash Flow from Financing Activities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-70 Cr |
| Mar2025 | ₹-73 Cr |
| Mar2024 | ₹-59 Cr |
| Mar2023 | ₹-26 Cr |
| Mar2022 | ₹-49 Cr |
How is Cash Flow from Financing Activities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-70 Cr | Negative | |
| Mar2025 | ₹-73 Cr | Negative | |
| Mar2024 | ₹-59 Cr | Negative | |
| Mar2023 | ₹-26 Cr | Negative | |
| Mar2022 | ₹-49 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,723.4 Cr | 8.7% | 3.6% | -7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 8.7% |
3.6% |
-7.3% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses